Steven L. Hoerter
2020 - Deciphera Pharmaceuticals
In 2020, Steven L. Hoerter earned a total compensation of $7.8M as President and Chief Executive Officer at Deciphera Pharmaceuticals, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $536,250 |
|---|---|
| Option Awards | $6,597,306 |
| Salary | $650,000 |
| Other | $11,388 |
| Total | $7,794,944 |
Hoerter received $6.6M in option awards, accounting for 85% of the total pay in 2020.
Hoerter also received $536.3K in non-equity incentive plan, $650K in salary and $11.4K in other compensation.
Rankings
In 2020, Steven L. Hoerter's compensation ranked 1,202nd out of 13,090 executives tracked by ExecPay. In other words, Hoerter earned more than 90.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,202 out of 13,090 | 91st |
Division Manufacturing | 426 out of 5,621 | 92nd |
Major group Chemicals And Allied Products | 147 out of 2,254 | 94th |
Industry group Drugs | 127 out of 1,954 | 94th |
Industry Pharmaceutical Preparations | 94 out of 1,459 | 94th |
Source: SEC filing on April 26, 2022.
Hoerter's colleagues
We found four more compensation records of executives who worked with Steven L. Hoerter at Deciphera Pharmaceuticals in 2020.